Ποια είναι η κεφαλαιοποίηση αγοράς για Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020)

Η κεφαλαιοποίηση αγοράς για Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020) είναι $1.63B

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020) Τιμή και Κεφαλαιοποίηση Αγοράς

Q: Ποια είναι η τιμή για Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020)

Η τιμή για Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020) είναι $1.89

Zhejiang Jingxin Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the full spectrum of pharmaceutical activities, from research and development to manufacturing and sales within the country. Its diverse product line includes active pharmaceutical ingredients (APIs), along with a wide array of finished medications such as antihypertensives, various antibiotics (including quinolones and cephalosporins), gastrointestinal remedies, antidiabetics, antipileptics, antihistamines, H+ pump inhibitors, H2 receptor blockers, cholesterol-lowering drugs, and antidepressants, as well as biopharmaceutical products. Additionally, the company is a provider of advanced medical display solutions, offering diagnostic, surgical, clinical, large-screen, integrated, and ultrasonic medical displays. Originally founded in 1974 as Zhejiang Jingxin Pharmaceutical Factory, the company officially rebranded to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000 and maintains its headquarters in Xinchang, China.

Η τιμή για 002020	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$6,424.40 $1.63B	NVDA	$5.532T	+339,352.58%
$5,351.92 $1.63B	AAPL	$4.608T	+282,684.98%
$4,756.66 $1.63B	GOOG	$4.096T	+251,232.76%
$4,353.42 $1.63B	MSFT	$3.748T	+229,926.01%
$3,207.04 $1.63B	AMZN	$2.761T	+169,353.50%

Η τιμή για 002020

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$6,424.40 $1.63B